학술논문

Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy.
Document Type
article
Source
Blood cancer journal. 5(2)
Subject
Humans
Leukemia
Myeloproliferative Disorders
Eosinophilia
Hypereosinophilic Syndrome
Benzamides
Piperazines
Pyrimidines
Tankyrases
Receptor
Platelet-Derived Growth Factor alpha
Oncogene Proteins
Fusion
Genome
Human
Middle Aged
Female
High-Throughput Nucleotide Sequencing
Imatinib Mesylate
Cardiorespiratory Medicine and Haematology
Oncology and Carcinogenesis
Language